This is the authors' abstract. We don't add key points for this paper.
OBJECTIVE: To examine the association between debridement timing and infection, readmission, and reoperation in open upper-limb fractures. DESIGN: Retrospective cohort study. SETTING: Academic Level 1 trauma center. PATIENT SELECTION CRITERIA: All patients with open upper limb fractures involving the humerus (AO/OTA 1), radius or ulna (AO/OTA 2), scapula (AO/OTA 14), or clavicle (AO/OTA 15) treated at a single academic Level I trauma center between 2014 and 2023 were included. Exclusions were isolated hand injuries, primary amputation, death before surgery, and incomplete records. OUTCOME MEASURES AND COMPARISONS: Patients were grouped based on time to debridement: ≤24 hours, 24-48 hours, and >48 hours. Multivariable logistic regression models adjusted for American Society of Anesthesiologists grade, Gustilo-Anderson classification, and Injury Severity Score (ISS) evaluated the association between timing and 30-day readmission, 90-day readmission, 1-year reoperation, and infection. RESULTS: The study included 297 patients [mean age 44.7 years (SD 22.5); 66.9% male]. Baseline demographics were similar across time-to-debridement groups (≤24 hours, n = 154; 24-48 hours, n = 83; >48 hours, n = 60) with no significant differences in age, sex, or ISS (all P > 0.05). Debridement within 24 hours occurred in 154 of 297 patients (51.9%), and 60 of 297 patients (20.2%) experienced delays >48 hours. Outcome rates were 30-day readmission in 18 of 297 patients (6.1%), 90-day readmission in 21 of 297 patients (7.1%), reoperation within 1 year in 44 of 297 patients (14.8%), and postoperative infection in 13 of 297 patients (4.4%). No statistically significant association was observed between debridement timing and 30-day readmission ( P = 0.72), 90-day readmission ( P = 0.83), 1-year reoperation ( P = 0.11), or infection ( P = 0.39). CONCLUSIONS: Within the studied intervals (≤24, 24-48, and >48 hours), debridement timing up to and including delays >48 hours was not significantly associated with readmission, reoperation within 1 year, or postoperative infection in open upper limb fractures. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
No takes yet. Share an insight, caveat, or question.
Beale et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: